These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 18645702)

  • 21. How many claudicants should be prescribed statins?
    Hobbs SD; Wilmink T; Bradbury AW
    Eur J Vasc Endovasc Surg; 2003 Jul; 26(1):110. PubMed ID: 12819659
    [No Abstract]   [Full Text] [Related]  

  • 22. Fibrates in the treatment of dyslipidemias--time for a reassessment.
    Goldfine AB; Kaul S; Hiatt WR
    N Engl J Med; 2011 Aug; 365(6):481-4. PubMed ID: 21830963
    [No Abstract]   [Full Text] [Related]  

  • 23. At which stage of chronic kidney disease should dyslipidemia be treated?
    Krane V; Wanner C
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):176-7. PubMed ID: 16932418
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of dyslipidemia in renal disease and transplantation.
    Zolezzi M
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):129-36. PubMed ID: 16903617
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of statins in primary prevention.
    Savill P
    Practitioner; 2009; 253(1720):7. PubMed ID: 19715050
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary prevention of cardiovascular disease with statins: cautionary notes.
    Goldstein MR; Mascitelli L; Pezzetta F
    QJM; 2009 Nov; 102(11):817-20. PubMed ID: 19620217
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimal management of persistent mixed dyslipidemia after statin initiation warrants combination therapy.
    Boden WE; McGovern ME
    Am J Cardiol; 2009 Dec; 104(12):1695-6. PubMed ID: 19962477
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preadmission use of statins as treatment for strokes].
    González-Hernández A; López-Fernández JC; Fabre-Pi O; Cubero A
    Rev Neurol; 2007 Dec 1-15; 45(11):702-3. PubMed ID: 18050107
    [No Abstract]   [Full Text] [Related]  

  • 30. Addressing key questions with statin therapy.
    Toth PP
    J Fam Pract; 2012 Jun; 61(6 Suppl):S34-9. PubMed ID: 22670245
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mediterranean diet and statins against cardiovascular disease].
    Håkansson J
    Lakartidningen; 2012 Sep 5-11; 109(36):1540-3. PubMed ID: 23016236
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic determinants of response to statins.
    Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins in patients with chronic kidney disease: a double-edged sword?
    Kassimatis TI; Konstantinopoulos PA
    J Am Coll Cardiol; 2008 Nov; 52(20):1679; author reply 1680. PubMed ID: 18992660
    [No Abstract]   [Full Text] [Related]  

  • 35. Exploring the gap between National Cholesterol Education Program guidelines and clinical practice in secondary care: results of a cross-sectional study involving over 10 000 patients followed in different specialty settings across Italy.
    Rapezzi C; Biagini E; Bellis P; Cafiero M; Velussi M; Ceriello A; Cooke RM; Schweiger C;
    J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):878-87. PubMed ID: 18695423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of statins in primary prevention of cardiovascular disease.
    Eichler K; Puhan MA; Bachmann LM
    Arch Intern Med; 2007 May; 167(10):1100; author reply 1100-1. PubMed ID: 17533216
    [No Abstract]   [Full Text] [Related]  

  • 37. Unhealthy lifestyle, statins and the secondary prevention of cardiovascular disease.
    Mascitelli L; Pezzetta F
    Intern Med J; 2007 Jun; 37(6):427-8. PubMed ID: 17535398
    [No Abstract]   [Full Text] [Related]  

  • 38. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.
    Gorkin JU; Watson K; Knopp RH
    J Fam Pract; 2007 Aug; 56(8 Suppl Strategies):S1-7; quiz S8. PubMed ID: 18667138
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular risk profile and use of statins at the age of 70 years: a comparison of two Finnish birth cohorts born 20 years apart.
    Upmeier E; Vire J; Korhonen MJ; Isoaho H; Lehtonen A; Arve S; Wuorela M; Viitanen M
    Age Ageing; 2016 Jan; 45(1):84-90. PubMed ID: 26764397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using statins to reduce cardiovascular risk after carotid endarterectomy.
    Floros G; Anagnostou V; Tsiga E; Ferenidou F; Papadimitriou D
    Evid Based Cardiovasc Med; 2006 Mar; 10(1):1-4. PubMed ID: 16530653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.